Allergy immunotherapy scheduling software and vial tracking
An allergy practice runs two schedules at once. One is the patient’s. The other belongs to a vial in a refrigerator, and almost no practice manages it with the same seriousness.
Allergy immunotherapy scheduling software has to hold three things together: which patient is on which protocol and where in it, which vial and dilution their next dose comes from, and what happens when they miss. Most systems do the first well and the other two on paper.
Immunotherapy is the only treatment in most allergy practices that runs for years.
A patient starting build-up may come twice a week for months, then monthly for three more years. Across that time the protocol steps up through dilutions, the vials are remade, staff turn over, and the patient moves house. Nothing about that is clinically complicated. It is an administrative endurance test, and the record is what fails first.
The failure is rarely a wrong injection. It is far more often a patient who quietly stops coming and nobody notices, or a dose given from a vial that was remade last week by someone who wrote it on a different sheet.
The build-up phase and why the calendar is clinical
Build-up is the stretch where the dose climbs, and it is the stretch where scheduling stops being administrative. The interval between injections is part of the protocol, not a convenience. A patient who comes three days late is in a different clinical position from one who comes on time, and the person drawing the dose needs to know that before they draw it.
Which means the schedule has to expose the last injection date, the step reached, and any reaction recorded at that step, at the moment the appointment is booked and again at the moment the dose is prepared. Practices that keep this in a paper flow sheet manage it perfectly well right up until the person who knows the sheet is on leave.
This is worth designing rather than inheriting. The default configuration in most ambulatory platforms treats an injection visit as a nurse visit with no clinical state attached, which is how a four-year protocol ends up being tracked in the margin of a printout.
Extract preparation is a separate billable act
There is a coding distinction here that carries a documentation requirement with it, and getting it wrong is both a billing problem and a record problem. Medicare separates the professional administration of the injection from the preparation of the antigen vial.
The CMS billing and coding article for allergy immunotherapy sets out the split plainly: the injection codes cover “professional administration (injection) of the allergenic extract, when the extract is not included in the code descriptor,” while the preparation code covers preparation of the vial and not the injection. The same article states that a physician “may not bill this vial preparation code for more than 10 doses per vial.”
Read that last line as a data requirement rather than a billing rule. To bill preparation by the dose, the practice has to know how many doses came out of a specific vial. That is a count that lives in the vial record or nowhere.
- If your system cannot tell you how many doses have been drawn from a given vial, you do not have extract preparation documented — you have it estimated. Those are different things when somebody asks.
Vial tracking: the part the schedule depends on
A vial record that works holds the patient it belongs to, the antigens and dilution, the date it was made and by whom, the expiry, the lot numbers of the source extracts, and a running count of doses drawn. Six fields and a counter.
The source extracts themselves arrive as licensed biologics with their own controls. Federal regulation requires that “a sterility test shall be performed on each lot of each Allergenic Product” and that the potency of each lot be determined before release. FDA also draws a line practices should carry into their own records: for standardized extracts there is an established method to determine potency lot by lot, while non-standardized products have no such measure.
None of that governs what happens after the bottle reaches your refrigerator. That part is entirely your record, which is exactly why it deserves to be a structured one. Capturing source lot numbers on the vial record is the difference between a five-minute answer and a two-day search if a product is ever recalled.
Missed dose protocol, encoded rather than remembered
Every allergy practice has a rule for what happens when a patient misses. Most have it in a physician’s head, a laminated card, or both, in versions that differ slightly.
The rule is a lookup: how far past the interval, at which step, on which dilution, produces which adjustment. That is a table, and a table belongs in the system rather than on the wall. Encoding it does two things. It makes the decision consistent across nurses and across locations, and it creates a record showing why a dose was reduced, which is the documentation you want if a reaction follows.
Building it is not a large project. Writing the table down and getting the physicians to agree on it is usually the longer half, and it is worth doing at the same time as rebuilding the injection workflow around it rather than afterwards.
Not sure your vial record and your schedule agree?
We trace how a dose gets from the refrigerator to the patient in your practice, find where the two records diverge, and hand you written findings.
Patient recall and the three-year problem
Maintenance is where immunotherapy quietly fails. A patient on monthly injections for three years has thirty-six chances to drift away, and the schedule will not flag it because there is no appointment to miss — there is only one that was never booked.
Patient recall has to run off the clinical state rather than the calendar. The question is not who cancelled; it is who is on maintenance and has not had an injection in longer than their interval allows. That is a report, it takes minutes to build in any certified system, and it needs a named owner to work it. NIH has noted that achieving persistent relief requires at least three years of allergy shots, so a patient who drifts at month fourteen has spent the effort without reaching the benefit.
Where a check-in is about tolerance and adherence rather than the injection itself, a virtual visit is often the faster way to close the loop, and it gets the patient back on the schedule rather than onto a callback list.
What to fix first
- Put the vial record in the chart. Patient, antigens, dilution, made-by, made-on, expiry, source lots, dose count. Not a card in the fridge.
- Write the missed dose table down. One page, agreed by the physicians, then encoded.
- Build the overdue-maintenance report before any new software. It is the cheapest thing on this list and it finds patients this month.
- Name an owner for recall. By name, before the first list is generated.
In our experience practices that do those four find the scheduling product they were about to buy solves a problem they no longer have. Where a product is genuinely needed, the work sits inside our allergy and immunology EHR and IT support and a broader allergy immunology practice management engagement. Because a vial record identifies a patient by name alongside their treatment, it belongs in your HIPAA risk analysis as surely as the chart does.
Qventive provides allergy immunotherapy scheduling software help for medical practices across northern New Jersey, and the first conversation is usually about the vial record rather than the calendar.
Immunotherapy scheduling: common questions
Do we need dedicated immunotherapy software?
How should we handle a patient who transfers in mid-protocol?
What are the HIPAA implications of a vial refrigerator log?
Can we bill for preparing vials and giving the injection on the same day?
How long should we keep vial records after a course finishes?
Let’s meet
Qventive works with allergy and immunology practices across New Jersey on protocol design, vial tracking and recall. Thirty years healthcare-exclusive, from our office in Hackensack.
- Injection codes cover administration, 95165 covers vial preparation, and preparation may not be billed for more than 10 doses per vial. cms.gov
- Sterility and potency testing required on each lot of each allergenic product. ecfr.gov
- Standardized extracts have an established lot-by-lot potency method; non-standardized products do not. fda.gov
- Persistent symptom relief requires at least three years of allergy shots. nih.gov